Science 21 February 1992: Vol. 255. no. 5047, pp. 989 - 991 DOI: 10.1126/science.1312256

Prev | Table of Contents | Next

Articles

VEGF Gene Haplotypes Are Associated With Sarcoidosis.

S. Pabst, A. Karpushova, A. Diaz-Lacava, S. Herms, M. Walier, S. Zimmer, S. Cichon, G. Nickenig, M. M. Nothen, T. F. Wienker, et al. (2010)
Chest 137, 156-163
 |  Abstract »  |  Full Text »  |  PDF »

Expression of Soluble Vascular Endothelial Growth Factor Receptor-1 in Human Monocyte-Derived Mature Dendritic Cells Contributes to Their Antiangiogenic Property.

M. Kishuku, Y. Nishioka, S. Abe, J. Kishi, H. Ogino, Y. Aono, M. Azuma, K. Kinoshita, B. Rentsenhand, H. Makino, et al. (2009)
J. Immunol. 183, 8176-8185
 |  Abstract »  |  Full Text »  |  PDF »

Vascular Endothelial Growth Factor Receptor-1 Is Synthetic Lethal to Aberrant {beta}-Catenin Activation in Colon Cancer.

S. Naik, R. S. Dothager, J. Marasa, C. L. Lewis, and D. Piwnica-Worms (2009)
Clin. Cancer Res. 15, 7529-7537
 |  Abstract »  |  Full Text »  |  PDF »

Compartmentalizing VEGF-Induced ERK2/1 Signaling in Placental Artery Endothelial Cell Caveolae: A Paradoxical Role of Caveolin-1 in Placental Angiogenesis in Vitro.

W.-x. Liao, L. Feng, H. Zhang, J. Zheng, T. R. Moore, and D.-b. Chen (2009)
Mol. Endocrinol. 23, 1428-1444
 |  Abstract »  |  Full Text »  |  PDF »

VEGFR-1 Regulates Adult Olfactory Bulb Neurogenesis and Migration of Neural Progenitors in the Rostral Migratory Stream In Vivo.

I. M. Wittko, A. Schanzer, A. Kuzmichev, F. T. Schneider, M. Shibuya, S. Raab, and K. H. Plate (2009)
J. Neurosci. 29, 8704-8714
 |  Abstract »  |  Full Text »  |  PDF »

Signaling mechanism of extracellular RNA in endothelial cells.

S. Fischer, M. Nishio, S. C. Peters, M. Tschernatsch, M. Walberer, S. Weidemann, R. Heidenreich, P. O. Couraud, B. B. Weksler, I. A. Romero, et al. (2009)
FASEB J 23, 2100-2109
 |  Abstract »  |  Full Text »  |  PDF »

Vascular Endothelial Growth Factor.

N. Ferrara (2009)
Arterioscler Thromb Vasc Biol 29, 789-791
 |  Abstract »  |  Full Text »  |  PDF »

The forming limb skeleton serves as a signaling center for limb vasculature patterning via regulation of Vegf.

I. Eshkar-Oren, S. V. Viukov, S. Salameh, S. Krief, C.-d. Oh, H. Akiyama, H.-P. Gerber, N. Ferrara, and E. Zelzer (2009)
Development 136, 1263-1272
 |  Abstract »  |  Full Text »  |  PDF »

Identification of Ligand-Induced Proteolytic Cleavage and Ectodomain Shedding of VEGFR-1/FLT1 in Leukemic Cancer Cells.

N. Rahimi, T. E. Golde, and R. D. Meyer (2009)
Cancer Res. 69, 2607-2614
 |  Abstract »  |  Full Text »  |  PDF »

Broad Antitumor Activity in Breast Cancer Xenografts by Motesanib, a Highly Selective, Oral Inhibitor of Vascular Endothelial Growth Factor, Platelet-Derived Growth Factor, and Kit Receptors.

A. Coxon, T. Bush, D. Saffran, S. Kaufman, B. Belmontes, K. Rex, P. Hughes, S. Caenepeel, J. B. Rottman, A. Tasker, et al. (2009)
Clin. Cancer Res. 15, 110-118
 |  Abstract »  |  Full Text »  |  PDF »

Targeted therapies for pancreatic cancer.

S. A. Danovi, H. H. Wong, and N. R. Lemoine (2008)
Br. Med. Bull. 87, 97-130
 |  Abstract »  |  Full Text »  |  PDF »

Relationship Between Retention of a Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)-Targeted Ultrasonographic Contrast Agent and the Level of VEGFR2 Expression in an In Vivo Breast Cancer Model.

D. J. Lee, A. Lyshchik, J. Huamani, D. E. Hallahan, and A. C. Fleischer (2008)
J. Ultrasound Med. 27, 855-866
 |  Abstract »  |  Full Text »  |  PDF »

Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome.

S. R. Soares, R. Gomez, C. Simon, J. A. Garcia-Velasco, and A. Pellicer (2008)
Hum. Reprod. Update
 |  Abstract »  |  Full Text »  |  PDF »

Kaposi's Sarcoma-Associated Herpesvirus Induces Sustained Levels of Vascular Endothelial Growth Factors A and C Early during In Vitro Infection of Human Microvascular Dermal Endothelial Cells: Biological Implications.

R. Sivakumar, N. Sharma-Walia, H. Raghu, M. V. Veettil, S. Sadagopan, V. Bottero, L. Varga, R. Levine, and B. Chandran (2008)
J. Virol. 82, 1759-1776
 |  Abstract »  |  Full Text »  |  PDF »

Endogenous Vascular Endothelial Growth Factor-C Expression Is Associated with Decreased Drug Responsiveness in Childhood Acute Myeloid Leukemia.

H. J.M. de Jonge, A. C. Weidenaar, A. ter Elst, H. M. Boezen, F. J.G. Scherpen, J. C.A. Bouma-ter Steege, G. J.L. Kaspers, B. F. Goemans, U. Creutzig, M. Zimmermann, et al. (2008)
Clin. Cancer Res. 14, 924-930
 |  Abstract »  |  Full Text »  |  PDF »

Expression of Vascular Endothelial Growth Factor in Human Meningiomas and Peritumoral Brain Areas.

Y.-S. Ding, H.-D. Wang, K. Tang, Z.-G. Hu, W. Jin, and W. Yan (2008)
Ann. Clin. Lab. Sci. 38, 344-351
 |  Abstract »  |  Full Text »  |  PDF »

Inverse Prognostic Impact of Angiogenic Marker Expression in Tumor Cells versus Stromal Cells in Non Small Cell Lung Cancer.

T. Donnem, S. Al-Saad, K. Al-Shibli, M. P. Delghandi, M. Persson, M. N. Nilsen, L.-T. Busund, and R. M. Bremnes (2007)
Clin. Cancer Res. 13, 6649-6657
 |  Abstract »  |  Full Text »  |  PDF »

Immunohistochemical Expression of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor Associated with Tumor Cell Proliferation in Canine Cutaneous Squamous Cell Carcinomas and Trichoepitheliomas.

A. N. Al-Dissi, D. M. Haines, B. Singh, and B. A. Kidney (2007)
Vet. Pathol. 44, 823-830
 |  Abstract »  |  Full Text »  |  PDF »

Extracellular RNA mediates endothelial-cell permeability via vascular endothelial growth factor.

S. Fischer, T. Gerriets, C. Wessels, M. Walberer, S. Kostin, E. Stolz, K. Zheleva, A. Hocke, S. Hippenstiel, and K. T. Preissner (2007)
Blood 110, 2457-2465
 |  Abstract »  |  Full Text »  |  PDF »

Molecular Mapping and Functional Characterization of the VEGF164 Heparin-binding Domain.

D. Krilleke, A. DeErkenez, W. Schubert, I. Giri, G. S. Robinson, Y.-S. Ng, and D. T. Shima (2007)
J. Biol. Chem. 282, 28045-28056
 |  Abstract »  |  Full Text »  |  PDF »

Eyes wide s-flt: clearly, avascular fidelity is a vascular endothelial growth factor family affair.

R. Mohan (2007)
Br J Ophthalmol 91, 412-413
 |  Full Text »  |  PDF »

Des-{gamma}-carboxyl Prothrombin-promoted Vascular Endothelial Cell Proliferation and Migration.

T. Fujikawa, H. Shiraha, N. Ueda, N. Takaoka, Y. Nakanishi, N. Matsuo, S. Tanaka, S.-i. Nishina, M. Suzuki, A. Takaki, et al. (2007)
J. Biol. Chem. 282, 8741-8748
 |  Abstract »  |  Full Text »  |  PDF »

VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants.

J. L. Warner-Schmidt and R. S. Duman (2007)
PNAS 104, 4647-4652
 |  Abstract »  |  Full Text »  |  PDF »

Sorafenib in Renal Cell Carcinoma.

K. T. Flaherty (2007)
Clin. Cancer Res. 13, 747s-752s
 |  Abstract »  |  Full Text »  |  PDF »

Latent Kaposi's Sarcoma-Associated Herpesvirus Infection of Endothelial Cells Activates Hypoxia-Induced Factors.

P. A. Carroll, H. L. Kenerson, R. S. Yeung, and M. Lagunoff (2006)
J. Virol. 80, 10802-10812
 |  Abstract »  |  Full Text »  |  PDF »

An antiangiogenic neurokinin-B/thromboxane A2 regulatory axis.

S. Pal, J. Wu, J. K. Murray, S. H. Gellman, M. A. Wozniak, P. J. Keely, M. E. Boyer, T. M. Gomez, S. M. Hasso, J. F. Fallon, et al. (2006)
J. Cell Biol. 174, 1047-1058
 |  Abstract »  |  Full Text »  |  PDF »

Exercise training improves aging-induced downregulation of VEGF angiogenic signaling cascade in hearts.

M. Iemitsu, S. Maeda, S. Jesmin, T. Otsuki, and T. Miyauchi (2006)
Am J Physiol Heart Circ Physiol 291, H1290-H1298
 |  Abstract »  |  Full Text »  |  PDF »

VEGF Activates Receptor-Operated Cation Channels in Human Microvascular Endothelial Cells.

H.-W. Cheng, A.F. James, R.R. Foster, J.C. Hancox, and D.O. Bates (2006)
Arterioscler Thromb Vasc Biol 26, 1768-1776
 |  Abstract »  |  Full Text »  |  PDF »

Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP.

F. Guan, G. Villegas, J. Teichman, P. Mundel, and A. Tufro (2006)
Am J Physiol Renal Physiol 291, F422-F428
 |  Abstract »  |  Full Text »  |  PDF »

Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome.

E. Pau, I. Alonso-Muriel, R. Gomez, E. Novella, A. Ruiz, J. A. Garcia-Velasco, C. Simon, and A. Pellicer (2006)
Hum. Reprod. 21, 1453-1460
 |  Abstract »  |  Full Text »  |  PDF »

Inhibition of growth factor-induced Ras signaling in vascular endothelial cells and angiogenesis by 3,3'-diindolylmethane.

X. Chang, G. L. Firestone, and L. F. Bjeldanes (2006)
Carcinogenesis 27, 541-550
 |  Abstract »  |  Full Text »  |  PDF »

Loss of Tie2 receptor compromises embryonic stem cell-derived endothelial but not hematopoietic cell survival.

I. Hamaguchi, T. Morisada, M. Azuma, K. Murakami, M. Kuramitsu, T. Mizukami, K. Ohbo, K. Yamaguchi, Y. Oike, D. J. Dumont, et al. (2006)
Blood 107, 1207-1213
 |  Abstract »  |  Full Text »  |  PDF »

A Single Amino Acid Substitution in the Activation Loop Defines the Decoy Characteristic of VEGFR-1/FLT-1.

R. D. Meyer, M. Mohammadi, and N. Rahimi (2006)
J. Biol. Chem. 281, 867-875
 |  Abstract »  |  Full Text »  |  PDF »

Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions.

M.W. Laschke, A. Elitzsch, B. Vollmar, P. Vajkoczy, and M.D. Menger (2006)
Hum. Reprod. 21, 262-268
 |  Abstract »  |  Full Text »  |  PDF »

Riluzole Inhibits VEGF-Induced Endothelial Cell Proliferation In Vitro and Hyperoxia-Induced Abnormal Vessel Formation In Vivo.

M. H. Yoo, H.-J. Hyun, J.-Y. Koh, and Y. H. Yoon (2005)
Invest. Ophthalmol. Vis. Sci. 46, 4780-4787
 |  Abstract »  |  Full Text »  |  PDF »

Vascular Endothelial Growth Factor Contributes to Prostate Cancer-Mediated Osteoblastic Activity.

Y. Kitagawa, J. Dai, J. Zhang, J. M. Keller, J. Nor, Z. Yao, and E. T. Keller (2005)
Cancer Res. 65, 10921-10929
 |  Abstract »  |  Full Text »  |  PDF »

Hypoxia Induces the Expression of Membrane-Type 1 Matrix Metalloproteinase in Retinal Glial Cells.

K. Noda, S. Ishida, H. Shinoda, T. Koto, T. Aoki, K. Tsubota, Y. Oguchi, Y. Okada, and E. Ikeda (2005)
Invest. Ophthalmol. Vis. Sci. 46, 3817-3824
 |  Abstract »  |  Full Text »  |  PDF »

A Synthetic Glycosaminoglycan Mimetic Binds Vascular Endothelial Growth Factor and Modulates Angiogenesis.

V. Rouet, Y. Hamma-Kourbali, E. Petit, P. Panagopoulou, P. Katsoris, D. Barritault, J.-P. Caruelle, and J. Courty (2005)
J. Biol. Chem. 280, 32792-32800
 |  Abstract »  |  Full Text »  |  PDF »

Identification of Vascular Endothelial Growth Factor Receptor-binding Protein in the Venom of Eastern Cottonmouth: A NEW ROLE OF SNAKE VENOM MYOTOXIC LYS49-PHOSPHOLIPASE A2.

Y. Yamazaki, Y. Matsunaga, Y. Nakano, and T. Morita (2005)
J. Biol. Chem. 280, 29989-29992
 |  Abstract »  |  Full Text »  |  PDF »

VEGF is crucial for the hepatic vascular development required for lipoprotein uptake.

B. Carpenter, Y. Lin, S. Stoll, R. L. Raffai, R. McCuskey, and R. Wang (2005)
Development 132, 3293-3303
 |  Abstract »  |  Full Text »  |  PDF »

Gene expression analysis of Tek/Tie2 signaling.

S. H. Chen, Y. Babichev, N. Rodrigues, D. Voskas, L. Ling, V. P. K. H. Nguyen, and D. J. Dumont (2005)
Physiol Genomics 22, 257-267
 |  Abstract »  |  Full Text »  |  PDF »

Neuropilin-1 Regulates Vascular Endothelial Growth Factor-Mediated Endothelial Permeability.

P. M. Becker, J. Waltenberger, R. Yachechko, T. Mirzapoiazova, J. S.K. Sham, C. G. Lee, J. A. Elias, and A. D. Verin (2005)
Circ. Res. 96, 1257-1265
 |  Abstract »  |  Full Text »  |  PDF »

Expression of vascular endothelial growth factors and their receptors in human endometrium from women experiencing abnormal bleeding patterns after prolonged use of a levonorgestrel-releasing intrauterine system.

B. Moller, M. Ronnerdag, G. Wang, V. Odlind, and M. Olovsson (2005)
Hum. Reprod. 20, 1410-1417
 |  Abstract »  |  Full Text »  |  PDF »

Anti-Flt1 Peptide, a Vascular Endothelial Growth Factor Receptor 1-Specific Hexapeptide, Inhibits Tumor Growth and Metastasis.

D.-G. Bae, T.-D. Kim, G. Li, W.-H. Yoon, and C.-B. Chae (2005)
Clin. Cancer Res. 11, 2651-2661
 |  Abstract »  |  Full Text »  |  PDF »

Identification of biomarkers for tumor endothelial cell proliferation through gene expression profiling.

J. S. Hardwick, Y. Yang, C. Zhang, B. Shi, R. McFall, E. J. Koury, S. L. Hill, H. Dai, R. Wasserman, R. L. Phillips, et al. (2005)
Mol. Cancer Ther. 4, 413-425
 |  Abstract »  |  Full Text »  |  PDF »

The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications.

K. Podar and K. C. Anderson (2005)
Blood 105, 1383-1395
 |  Abstract »  |  Full Text »  |  PDF »

Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis.

D. J. Hicklin and L. M. Ellis (2005)
J. Clin. Oncol. 23, 1011-1027
 |  Abstract »  |  Full Text »  |  PDF »

Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice.

Y. Sakurai, K. Ohgimoto, Y. Kataoka, N. Yoshida, and M. Shibuya (2005)
PNAS 102, 1076-1081
 |  Abstract »  |  Full Text »  |  PDF »

VEGF Trap as a Novel Antiangiogenic Treatment Currently in Clinical Trials for Cancer and Eye Diseases, and VelociGene(R)- based Discovery of the Next Generation of Angiogenesis Targets.

J.S. RUDGE, G. THURSTON, S. DAVIS, N. PAPADOPOULOS, N. GALE, S.J. WIEGAND, and G.D. YANCOPOULOS (2005)
Cold Spring Harb Symp Quant Biol 70, 411-418
 |  Abstract »  |  PDF »

Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes.

R. R. Foster, M. A. Saleem, P. W. Mathieson, D. O. Bates, and S. J. Harper (2005)
Am J Physiol Renal Physiol 288, F48-F57
 |  Abstract »  |  Full Text »  |  PDF »

Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy.

T Yanagawa, T Funasaka, S Tsutsumi, H Watanabe, and A Raz (2004)
Endocr. Relat. Cancer 11, 749-759
 |  Abstract »  |  Full Text »  |  PDF »

Characterization of Vascular Endothelial Growth Factor (VEGF) in the Uterine Cervix over Pregnancy: Effects of Denervation and Implications for Cervical Ripening.

C.N. Mowa, S. Jesmin, I. Sakuma, S. Usip, H. Togashi, M. Yoshioka, Y. Hattori, and R. Papka (2004)
J. Histochem. Cytochem. 52, 1665-1674
 |  Abstract »  |  Full Text »  |  PDF »

Raf-Induced Vascular Endothelial Growth Factor Augments Kaposi's Sarcoma-Associated Herpesvirus Infection.

K. E. Hamden, P. W. Ford, A. G. Whitman, O. F. Dyson, S.-Y. Cheng, J. A. McCubrey, and S. M. Akula (2004)
J. Virol. 78, 13381-13390
 |  Abstract »  |  Full Text »  |  PDF »

Vascular Endothelial Growth Factor- and Thrombin-induced Termination Factor, Down Syndrome Critical Region-1, Attenuates Endothelial Cell Proliferation and Angiogenesis.

T. Minami, K. Horiuchi, M. Miura, Md. R. Abid, W. Takabe, N. Noguchi, T. Kohro, X. Ge, H. Aburatani, T. Hamakubo, et al. (2004)
J. Biol. Chem. 279, 50537-50554
 |  Abstract »  |  Full Text »  |  PDF »

c-Myc Interacts with Hypoxia to Induce Angiogenesis In vivo by a Vascular Endothelial Growth Factor-Dependent Mechanism.

U. E. Knies-Bamforth, S. B. Fox, R. Poulsom, G. I. Evan, and A. L. Harris (2004)
Cancer Res. 64, 6563-6570
 |  Abstract »  |  Full Text »  |  PDF »

Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia.

R. Kunstfeld, S. Hirakawa, Y.-K. Hong, V. Schacht, B. Lange-Asschenfeldt, P. Velasco, C. Lin, E. Fiebiger, X. Wei, Y. Wu, et al. (2004)
Blood 104, 1048-1057
 |  Abstract »  |  Full Text »  |  PDF »

Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression.

S. Kumar, T. E. Witzig, M. Timm, J. Haug, L. Wellik, T. K. Kimlinger, P. R. Greipp, and S. V. Rajkumar (2004)
Blood 104, 1159-1165
 |  Abstract »  |  Full Text »  |  PDF »

Dose-dependent response of FGF-2 for lymphangiogenesis.

L. K. Chang, G. Garcia-Cardena, F. Farnebo, M. Fannon, E. J. Chen, C. Butterfield, M. A. Moses, R. C. Mulligan, J. Folkman, and A. Kaipainen (2004)
PNAS 101, 11658-11663
 |  Abstract »  |  Full Text »  |  PDF »

Vascular Endothelial Growth Factor: Basic Science and Clinical Progress.

N. Ferrara (2004)
Endocr. Rev. 25, 581-611
 |  Abstract »  |  Full Text »  |  PDF »

Effects of specific signal transduction inhibitors on increased permeability across rat endothelial monolayers induced by neuropeptide Y or VEGF.

N. Kurimoto, Y.-S. Nan, Z.-Y. Chen, G.-G. Feng, T. Komatsu, N. Kandatsu, J. Ko, N. Kawai, and N. Ishikawa (2004)
Am J Physiol Heart Circ Physiol 287, H100-H106
 |  Abstract »  |  Full Text »  |  PDF »

Vascular Endothelial Growth Factor and Its Receptor, Flk-1/KDR, Are Cytoprotective in the Extravascular Compartment of the Ovarian Follicle.

J. Greenaway, K. Connor, H. G. Pedersen, B. L. Coomber, J. LaMarre, and J. Petrik (2004)
Endocrinology 145, 2896-2905
 |  Abstract »  |  Full Text »  |  PDF »

Bifunctional Properties of Peroxisome Proliferator-Activated Receptor {gamma}1 in KDR Gene Regulation Mediated via Interaction With Both Sp1 and Sp3.

Y. Sassa, Y. Hata, L. P. Aiello, Y. Taniguchi, K. Kohno, and T. Ishibashi (2004)
Diabetes 53, 1222-1229
 |  Abstract »  |  Full Text »  |  PDF »

Expression and Function of the Vascular Endothelial Growth Factor Receptor FLT-1 in Human Eosinophils.

C. Feistritzer, N. C. Kaneider, D. H. Sturn, B. A. Mosheimer, C. M. Kahler, and C. J. Wiedermann (2004)
Am. J. Respir. Cell Mol. Biol. 30, 729-735
 |  Abstract »  |  Full Text »  |  PDF »

Vascular endothelial growth factor gene polymorphisms and pre-eclampsia.

D. Papazoglou, G. Galazios, M. I. Koukourakis, I. Panagopoulos, E. N. Kontomanolis, K. Papatheodorou, and E. Maltezos (2004)
Mol. Hum. Reprod. 10, 321-324
 |  Abstract »  |  Full Text »  |  PDF »

Circulating levels of free and total vascular endothelial growth factor (VEGF)-A, soluble VEGF receptors-1 and -2, and angiogenin during ovarian stimulation in non-human primates and women.

T.A. Molskness, R.L. Stouffer, K.A. Burry, M.J. Gorrill, D.M. Lee, and P.E. Patton (2004)
Hum. Reprod. 19, 822-830
 |  Abstract »  |  Full Text »  |  PDF »

Vascular Endothelial Growth Factor Activation of Intramembranous Absorption: A Critical Pathway for Amniotic Fluid Volume Regulation.

C. Y. Cheung (2004)
Reproductive Sciences 11, 63-74
 |  Abstract »  |  PDF »

sFlt-1 Gene Therapy of Follicular Thyroid Carcinoma.

C. Ye, C. Feng, S. Wang, K. Z. Q. Wang, N. Huang, X. Liu, Y. Lin, and M. Li (2004)
Endocrinology 145, 817-822
 |  Abstract »  |  Full Text »  |  PDF »

The Carboxyl Terminus Controls Ligand-dependent Activation of VEGFR-2 and Its Signaling.

R. D. Meyer, A. J. Singh, and N. Rahimi (2004)
J. Biol. Chem. 279, 735-742
 |  Abstract »  |  Full Text »  |  PDF »

VEGF and KDR Gene Expression during Human Embryonic and Fetal Eye Development.

K. Gogat, L. Le Gat, L. Van Den Berghe, D. Marchant, A. Kobetz, S. Gadin, B. Gasser, I. Quere, M. Abitbol, and M. Menasche (2004)
Invest. Ophthalmol. Vis. Sci. 45, 7-14
 |  Abstract »  |  Full Text »  |  PDF »

Snake Venom Vascular Endothelial Growth Factors (VEGFs) Exhibit Potent Activity through Their Specific Recognition of KDR (VEGF Receptor 2).

Y. Yamazaki, K. Takani, H. Atoda, and T. Morita (2003)
J. Biol. Chem. 278, 51985-51988
 |  Abstract »  |  Full Text »  |  PDF »

Trophoblast expression of fms-like tyrosine kinase 1 is not required for the establishment of the maternal-fetal interface in the mouse placenta.

M. Hirashima, Y. Lu, L. Byers, and J. Rossant (2003)
PNAS 100, 15637-15642
 |  Abstract »  |  Full Text »  |  PDF »

Perlecan and Tumor Angiogenesis.

X. Jiang and J. R. Couchman (2003)
J. Histochem. Cytochem. 51, 1393-1410
 |  Abstract »  |  Full Text »  |  PDF »

Overexpression of the Soluble Vascular Endothelial Growth Factor Receptor in Preeclamptic Patients: Pathophysiological Consequences.

V. Tsatsaris, F. Goffin, C. Munaut, J.-F. Brichant, M.-R. Pignon, A. Noel, J.-P. Schaaps, D. Cabrol, F. Frankenne, and J.-M. Foidart (2003)
J. Clin. Endocrinol. Metab. 88, 5555-5563
 |  Abstract »  |  Full Text »  |  PDF »

A Molecular Mechanism Regulating Circadian Expression of Vascular Endothelial Growth Factor in Tumor Cells.

S. Koyanagi, Y. Kuramoto, H. Nakagawa, H. Aramaki, S. Ohdo, S. Soeda, and H. Shimeno (2003)
Cancer Res. 63, 7277-7283
 |  Abstract »  |  Full Text »  |  PDF »

Pharmacological Characterization of CP-547,632, a Novel Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for Cancer Therapy.

J. S. Beebe, J. P. Jani, E. Knauth, P. Goodwin, C. Higdon, A. M. Rossi, E. Emerson, M. Finkelstein, E. Floyd, S. Harriman, et al. (2003)
Cancer Res. 63, 7301-7309
 |  Abstract »  |  Full Text »  |  PDF »

Increased mRNA expression of vascular endothelial growth factor and its receptor (flt-1) in the hydrosalpinx.

P. M. Lam, C. Briton-Jones, C. K. Cheung, L. S. Po, L. P. Cheung, and C. Haines (2003)
Hum. Reprod. 18, 2264-2269
 |  Abstract »  |  Full Text »  |  PDF »

Vascular Endothelial Growth Factor Up-regulates Expression of Receptor Activator of NF-{kappa}B (RANK) in Endothelial Cells: CONCOMITANT INCREASE OF ANGIOGENIC RESPONSES TO RANK LIGAND.

J.-K. Min, Y.-M. Kim, Y.-M. Kim, E.-C. Kim, Y. S. Gho, I.-J. Kang, S.-Y. Lee, Y.-Y. Kong, and Y.-G. Kwon (2003)
J. Biol. Chem. 278, 39548-39557
 |  Abstract »  |  Full Text »  |  PDF »

Nuclear Translocation of Phosphorylated STAT3 Is Essential for Vascular Endothelial Growth Factor-induced Human Dermal Microvascular Endothelial Cell Migration and Tube Formation.

Y. Yahata, Y. Shirakata, S. Tokumaru, K. Yamasaki, K. Sayama, Y. Hanakawa, M. Detmar, and K. Hashimoto (2003)
J. Biol. Chem. 278, 40026-40031
 |  Abstract »  |  Full Text »  |  PDF »

Mechanistic studies of a novel human fusion toxin composed of vascular endothelial growth factor (VEGF)121 and the serine protease granzyme B: Directed apoptotic events in vascular endothelial cells.

Y. Liu, L. H. Cheung, P. Thorpe, and M. G. Rosenblum (2003)
Mol. Cancer Ther. 2, 949-959
 |  Abstract »  |  Full Text »

Induction of Follicular Development by Direct Single Injection of Vascular Endothelial Growth Factor Gene Fragments into the Ovary of Miniature Gilts.

T. Shimizu, J.-Y. Jiang, K. Iijima, K. Miyabayashi, Y. Ogawa, H. Sasada, and E. Sato (2003)
Biol Reprod 69, 1388-1393
 |  Abstract »  |  Full Text »  |  PDF »

Viral Vascular Endothelial Growth Factors Vary Extensively in Amino Acid Sequence, Receptor-binding Specificities, and the Ability to Induce Vascular Permeability yet Are Uniformly Active Mitogens.

L. M. Wise, N. Ueda, N. H. Dryden, S. B. Fleming, C. Caesar, S. Roufail, M. G. Achen, S. A. Stacker, and A. A. Mercer (2003)
J. Biol. Chem. 278, 38004-38014
 |  Abstract »  |  Full Text »  |  PDF »

Vascular Endothelial Growth Factor Regulates Focal Adhesion Assembly in Human Brain Microvascular Endothelial Cells through Activation of the Focal Adhesion Kinase and Related Adhesion Focal Tyrosine Kinase.

H. K. Avraham, T.-H. Lee, Y. Koh, T.-A. Kim, S. Jiang, M. Sussman, A. M. Samarel, and S. Avraham (2003)
J. Biol. Chem. 278, 36661-36668
 |  Abstract »  |  Full Text »  |  PDF »

Structure and Inhibitory Effects on Angiogenesis and Tumor Development of a New Vascular Endothelial Growth Inhibitor.

L. Zilberberg, S. Shinkaruk, O. Lequin, B. Rousseau, M. Hagedorn, F. Costa, D. Caronzolo, M. Balke, X. Canron, O. Convert, et al. (2003)
J. Biol. Chem. 278, 35564-35573
 |  Abstract »  |  Full Text »  |  PDF »

Retinal Angiogenesis Is Mediated by an Interaction between the Angiotensin Type 2 Receptor, VEGF, and Angiopoietin.

S. Sarlos, B. Rizkalla, C. J. Moravski, Z. Cao, M. E. Cooper, and J. L. Wilkinson-Berka (2003)
Am. J. Pathol. 163, 879-887
 |  Abstract »  |  Full Text »  |  PDF »

Taurine Supplementation of a Low Protein Diet Fed to Rat Dams Normalizes the Vascularization of the Fetal Endocrine Pancreas.

S. Boujendar, E. Arany, D. Hill, C. Remacle, and B. Reusens (2003)
J. Nutr. 133, 2820-2825
 |  Abstract »  |  Full Text »  |  PDF »

Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the {alpha}5{beta}1 integrin.

A. Orecchia, P. M. Lacal, C. Schietroma, V. Morea, G. Zambruno, and C. M. Failla (2003)
J. Cell Sci. 116, 3479-3489
 |  Abstract »  |  Full Text »  |  PDF »

Placenta growth factor activates monocytes and correlates with sickle cell disease severity.

N. Perelman, S. K. Selvaraj, S. Batra, L. R. Luck, A. Erdreich-Epstein, T. D. Coates, V. K. Kalra, and P. Malik (2003)
Blood 102, 1506-1514
 |  Abstract »  |  Full Text »  |  PDF »

Imaging gastrointestinal tumours using vascular endothelial growth factor-165 (VEGF165) receptor scintigraphy.

S. Li, M. Peck-Radosavljevic, O. Kienast, J. Preitfellner, G. Hamilton, A. Kurtaran, C. Pirich, P. Angelberger, and R. Dudczak (2003)
Ann. Onc. 14, 1274-1277
 |  Abstract »  |  Full Text »  |  PDF »

Leptomeningeal dissemination at diagnosis of pediatric low-grade neuroepithelial tumors.

J. Hukin, J. Siffert, H. Cohen, L. Velasquez, D. Zagzag, and J. Allen (2003)
Neuro-oncol 5, 188-196
 |  Abstract »  |  PDF »

Modulation of placental vascular endothelial growth factor by leptin and hCG.

D. Islami, P. Bischof, and D. Chardonnens (2003)
Mol. Hum. Reprod. 9, 395-398
 |  Abstract »  |  Full Text »  |  PDF »

Intravenous Delivery of Adenovirus-mediated Soluble FLT-1 Results in Liver Toxicity.

P. J. Mahasreshti, M. Kataram, M. H. Wang, C. R. Stockard, W. E. Grizzle, D. Carey, G. P. Siegal, H. J. Haisma, R. D. Alvarez, and D. T. Curiel (2003)
Clin. Cancer Res. 9, 2701-2710
 |  Abstract »  |  Full Text »  |  PDF »

Vascular Endothelial Growth Factor-dependent Down-regulation of Flk-1/KDR Involves Cbl-mediated Ubiquitination: CONSEQUENCES ON NITRIC OXIDE PRODUCTION FROM ENDOTHELIAL CELLS.

M. Duval, S. Bedard-Goulet, C. Delisle, and J.-P. Gratton (2003)
J. Biol. Chem. 278, 20091-20097
 |  Abstract »  |  Full Text »  |  PDF »

A Set of Loop-1 and -3 Structures in the Novel Vascular Endothelial Growth Factor (VEGF) Family Member, VEGF-ENZ-7, Is Essential for the Activation of VEGFR-2 Signaling.

A. Kiba, N. Yabana, and M. Shibuya (2003)
J. Biol. Chem. 278, 13453-13461
 |  Abstract »  |  Full Text »  |  PDF »

Angiogenesis: basic pathophysiology and implications for disease.

D.C Felmeden, A.D Blann, and G.Y.H Lip (2003)
Eur. Heart J. 24, 586-603
 |  Full Text »  |  PDF »

Role for Extracellular Signal-Responsive Kinase-1 and -2 in Retinal Angiogenesis.

L. E. Bullard, X. Qi, and J. S. Penn (2003)
Invest. Ophthalmol. Vis. Sci. 44, 1722-1731
 |  Abstract »  |  Full Text »  |  PDF »

VEGF regulates the proliferation of acid-exposed alveolar lining epithelial cells.

A Ohwada, Y Yoshioka, K Iwabuchi, I Nagaoka, T Dambara, and Y Fukuchi (2003)
Thorax 58, 328-332
 |  Abstract »  |  Full Text »  |  PDF »

A chemically defined culture of VEGFR2+ cells derived from embryonic stem cells reveals the role of VEGFR1 in tuning the threshold for VEGF in developing endothelial cells.

M. Hirashima, M. Ogawa, S. Nishikawa, K. Matsumura, K. Kawasaki, M. Shibuya, and S.-I. Nishikawa (2003)
Blood 101, 2261-2267
 |  Abstract »  |  Full Text »  |  PDF »

Expression of Vascular Endothelial Growth Factor and the Effects on Bone Remodeling during Experimental Tooth Movement.

S. Kohno, M. Kaku, K. Tsutsui, M. Motokawa, J. Ohtani, K. Tenjo, Y. Tohma, C. Tokimasa, T. Fujita, T. Kawata, et al. (2003)
Journal of Dental Research 82, 177-182
 |  Abstract »  |  Full Text »  |  PDF »

To Advertise   |   Find Products